CRO Profil Institute forms strategic partnership with HighTide
Profil Institute and HighTide Biopharmaceutical have formed a strategic partnership focused on developing new therapies for diabetes and NAFLD/NASH.
Profil Institute and HighTide Biopharmaceutical have formed a strategic partnership focused on developing new therapies for diabetes and NAFLD/NASH.
The first of its kind trial has successfully identified several compounds to pursue and has given rise to more than a dozen drug development projects.
INC Research has announced that it has received the “Bronze Standard” as part of IAOCR’s Clinical Operations Workforce Quality Accreditation program.